AU2002330931A1 - Time release calcium sulfate matrix for bone augmentation - Google Patents
Time release calcium sulfate matrix for bone augmentationInfo
- Publication number
- AU2002330931A1 AU2002330931A1 AU2002330931A AU2002330931A AU2002330931A1 AU 2002330931 A1 AU2002330931 A1 AU 2002330931A1 AU 2002330931 A AU2002330931 A AU 2002330931A AU 2002330931 A AU2002330931 A AU 2002330931A AU 2002330931 A1 AU2002330931 A1 AU 2002330931A1
- Authority
- AU
- Australia
- Prior art keywords
- implant
- calcium sulfate
- kit
- polymer
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
INTERNATIONAL APPLICATION FOR LETTERS PATENT UNDER THE PATENT COOPERATION TREATY
BE IT KNOWN THAT We, John L. Ricci, Harold Alexander, and Bruce Hollander, all residents of the United States of America, have invented a certain new and useful improvement in a:
TITLE: Implant Composition With Controlled Resorption Rate for Stimulating Bone Growth and Method of Use.
BACKGROUND OF THE INVENTION
The repair of bone defects and augmentation of existing bone often require the use of permanent bio-resorbable materials. Such materials may include autogenous bone graft, allogeneic graft, allogeneic bone graft, or alloplastic materials inclusive of various calcium phosphate ceramics, calcium phosphate cements, calcium sulfate materials, bioglass materials, and composites or other combinations thereof. Calcium sulfate, which is a form of plaster of paris, is a fully bioresorbable material which, for sometime, has been commonly used in cement and pellet form to repair bone defects.
When calcium sulfate is used as a cement to fill a bone void, fracture, or other defect, this material dissolves at a rapid rate, i.e., approximately one millimeter per week from the exterior of the cement towards the center thereof. Research of the present inventors has shown that this material causes precipitation of calcium phosphate deposits as it is resorbed at the surgical site. These precipitates, it has been shown, stimulate and direct the formation of new bone. On the other hand, it is important for purposes of optimal result that calcium sulfate, calcium phosphate, or any other bone repair material stay at the surgical site for a considerable period of time in order to inhibit soft tissue filling of the defect and to stimulate bone repair. However, currently used calcium sulfate materials are resorbed by human bone within two to seven weeks, depending upon the calcium sulfate form and the particular surgical site, which cannot be retained at the site for longer periods. As noted, such material is resorbed faster than it can be replaced by new bone thereby reducing its value to both patient and practitioner.
As such, the principal concern and difficulty expressed by practitioners (such as orthopedics or maxiofacial surgeons) are that calcium sulfate materials bio-resorb or dissolve too rapidly at a surgical or a recipient site, and, thereby, outpace the formation of new bone in human patients. Therefore, a need arises for improved calcium sulfate based compositions which can resorb at the recipient site in a rate desirably matching the rate bone growth.
SUMMARY OF THE INVENTION
The present invention relates to an implant composition having controlled resorption rate in vivo for stimulating bone growth, a method of making the implant composition, and a kit of implant materials.
In one aspect of the present invention, an implant composition having controlled resorption rate comprises a calcium sulfate compound, polymer containing particles, and a setting agent for setting the calcium sulfate compound and the polymer containing particles into a heterogeneous solid composition. Upon setting, the calcium sulfate compound forms a matrix and the polymer containing particles settled within the matrix.
In another aspect, the present invention comprises a method of using implant materials to make the inventive implant composition for bone augmentation and bone defect reparation. The method comprises the steps of: (a) mixing a calcium sulfate compound and polymer containing particles with a setting agent into a mixture, (b) applying the mixture, either by filling in a recipient site with the mixture, or by coating the mixture on a surface of a surgical implant prior to introducing the surgical implant into the recipient site, and (c) setting the mixture into a heterogeneous solid composition.
In a further aspect, the present invention relates to a kit of implant materials for bone augmentation and bone defect reparation. The kit comprises (a) dry powder of a calcium sulfate compound, and (b) polymer containing particles. The kit can further comprise a setting agent packed in a container, and instructions on how to use the kit for preparing the implant composition.
It is accordingly an object of the present invention to provide an implant composition for the repair and augmentation of bone defects.
It is another object of the invention to provide an implant composition having controllable resorption rate in vivo, wherein the rate of resorption can be substantially matched to the rate of bone growth in a specific medical or dental application.
It is a further object of the invention to provide implant materials and a method for making the implant composition.
The above and yet other objects and advantages of the present invention will become apparent from the hereinafter set forth Brief Description of the Drawings and Detailed Description of the Invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a schematic view of an implant composition of one embodiment of the present invention immediately after introduction into a recipient site, showing the heterogeneous solid implant composition.
Fig. 2 is a view, sequential to that of Fig. 1 , showing a first phase of bioresorption of the implant composition at the recipient site.
Fig. 3 is a view sequential to that of Fig. 2 showing the beginning of resorption of the polymer containing particles of the implant composition.
Fig. 4 is a view, sequential to that of Fig. 3, showing the end result of the bioresorption of the implant composition, which results stimulated bone growth with diminishing level of the implant composition.
Fig. 5 is a cross-sectional schematic view of the implant composition of the present invention used with a surgical implant which has buttress threads.
Figs. 6 and 7 show a cross-sectional schematic view and a top view, respectively, of the implant composition of the present invention used with a surgical implant which has a smooth exterior surface.
DETAILED DESCRIPTION OF THE INVENTION
In one aspect of the present invention, an implant composition having controlled resorption rate comprises a calcium sulfate compound, polymer containing particles, and a setting agent for setting the calcium sulfate compound and the polymer containing particles into a heterogeneous solid composition. Upon setting, the calcium sulfate compound forms a matrix (M) and the polymer containing particles (P) settled within the matrix. Fig. 1 shows a cross-sectional schematic view of the heterogeneous solid implant composition before resorption occurs.
In another aspect, the present invention comprises a method of using implant materials to make the inventive implant composition for bone augmentation and bone defect reparation. The method comprises the steps of: (a) mixing a calcium sulfate compound and polymer containing particles with a setting agent into a mixture, (b) filing a recipient site with the mixture, and (c) setting the mixture into a heterogeneous solid composition.
The calcium sulfate compound is dry powder of calcium sulfate hemihydrate. Suitable setting agents include water, alkaline metal salt solutions such as a saline solution, and an accelerant aqueous solution
containing potassium salt. The setting agents set the implant materials into a heterogeneous solid composition, or a multiphasic cement with different speeds. The speed of setting can be controlled from seven minutes to one hour, depending on the setting agent used as well as desired surgical application. Among various setting agents, potassium salt solutions result in the fastest setting. For the purpose of the present invention, an aqueous solution containing potassium or sodium ions are preferably used. Most preferably, an aqueous solution containing potassium ions can be used. Suitable examples of potassium salts include potassium sulfate, potassium phosphate, and potassium fluoride. The concentration of potassium ion controls the speed of setting, the higher it is the faster the setting process. Preferably, the concentration of the potassium ions is in a range from about 0.01 molar to about 0.5 molar.
The polymer containing particles (P) comprises a calcium sulfate compound, and at least one resorbable polymer. The calcium sulfate compound in the polymer containing particles can be calcium sulfate dihydrate, also called preset calcium sulfate, or calcium sulfate hemihydrate, also called unset calcium sulfate, or a mixture thereof. In one embodiment, the calcium sulfate compound is mixed with a resorbable polymer to form the particles. The amount of resorbable polymer used in the particles controls resorption rate of the implant composition when it is implanted in a recipient
site. In an alternative embodiment, the calcium sulfate compound of the particles is encapsulated in a coating (C) of a resorbable polymer, as shown in Fig. 1. In this case, thickness of the resorbable polymer coating controls resorption rate of the implant composition in a recipient site. The thickness of the resorbable polymer coating is from about 2 μm to about 50 μm. For polymers that are only expected to last for a short time, a thin layer can be applied. For fast-resorbing coatings, or coatings expected to last for a long time, a thick coating can be applied. Furthermore, the resorbable polymer coating is not required to be a complete encapsulation. It has been observed that small local incomplete coatings, or coatings with defects (accidentally or intentionally), function as initial resorption sites of the polymer containing particles. An analogous situation can be found in time release medicine. It is known that medical pills with small controlled defects (drilled or molded) in polymer coatings are sometimes used to control drug release rates. A broad range of particle sizes can be used in the implant composition. The particle size can be determined depended on a particular application, and recipient site. For example, small particles are more suitable for dental fillings. On the other hand, larger pallets are more suitable for repairing bone fracture. Preferably, the particle size is more than 20 μm in diameter since when the particles are smaller than 20 μm, they may cause a negative foreign body response due to activation of macrophages.
In an additional embodiment, the particles can be made having combined characteristics of the two types of particles described above. Herein, the particles can include mixed calcium sulfate compound and a resorbable polymer, which are, additionally, encapsulated with a resorbable polymer coating.
In a further embodiment, the implant composition comprises two different types of polymer containing particles that have different rates of resorption. Such particles can, for example, be particles coated with different polymers, combinations of coated and mixed polymers, or particles with coating of different thickness, a typical range being 0.5 to 100 micrometers.
A wide variety of resorbable polymers can be used for the implant composition of the present invention. Suitable resorbable polymers include aliphatic polyesters of alpha-hydroxy acid derivatives, such as polyactides, polyglycolides, polydioxanone, and poly ε-caprolactone; hydrophobic polymers, such as carnuba waxes and their derivatives; water soluble polymers, such as poly(desaminotyrosyl-tyrosine ethyl ester carbonate), hereinafter poly (DTE carbonate) and their derivatives; and therapeutic polymers, such as those containing salicylate. A specific type of resorbable polymer can be selected depending on the purpose of applications, expected bone growth speed of a particular surgical site, and environment or condition
of a recipient site. For the purpose of the present invention, polyactides, polyglycolides and poly (DTE carbonate) are used preferably. It is known that polyactides, including D and L isomers, and DL copolymers of polylactic acid, have a long time history in their use as biomedical devices. These polymers are readily available commercially. The polyglycolides and poly (DTE carbonate) have also been used for bone reparation.
In general, resorbable polymers resorb slower in vivo than calcium sulfate compounds. Therefore, the amount of resorbable polymer used in the particles, mixed or coated, controls resorption rate of the implant composition when it is implanted in a recipient site. The polymer containing particles can comprise about 0.1 % to about 50% (w/w) of a resorbable polymer, with about 1.5% defining the best mode. When the amount of a resorbable polymer is too high, it may cause a negative body, that is, immune response. When used as a coating only, the above (w/w) range is about 0.1% to about 22%. The rate of resorption of the implant composition can be controlled of between three (3) and twenty eight (28) weeks, depending on the types and amount of polymers used.
In an additional embodiment, the present invention relates to a method of preparing the polymer containing particles. The polymer containing particles can be prepared by two methods: (1) a surface coating process, and
(2) bulk mixing of polymer and calcium sulfate. In the surface coating process, preformed calcium sulfate particles are mixed with a polymer solution. The polymer solution forms a liquid coating on the calcium sulfate particles, and is allowed to dry and to form a polymer surface coating on the particles. The coating thickness and amount of penetration into the calcium sulfate depend on the concentration of polymer in the solution, and viscosity of the solution. Examples of suitable organic solvent can be used to dissolve the polymer and make the polymer solution include acetone and chloroform. In the bulk mixing method, a fine granular form of a polymer is mixed with a granular form of calcium sulfate. The mixture is then pressed or rolled into larger particles.
Fig. 1 to Fig. 4 illustrate the resorption process of the implant composition of the present invention, and the mechanism of controlled resorption rate for a proper stimulation of bone growth. Fig. 1 shows the structure of the heterogeneous solid implant composition after the mixture of calcium sulfate compound, polymer encapsulated particles, and the setting agent is being applied in a recipient site, and set into a heterogeneous solid composition. Fig. 2 shows the first phase of bioresorption of the implant composition. The calcium sulfate compound in the matrix resorbs first, that is, the first two to four weeks after implantation, thereby forming a porous system which will fill with granulation tissue (G) during said timeframe. The process of
resorbing calcium sulfate forms_deposits of calcium phosphate (CP) which has function to encourage early bone ingrowth (B).
Fig. 3 shows the second phase of the resorption, i,e., resorption of the polymer containing particles. This occurs as early as four weeks or as late as twenty weeks after applying the implant composition, depending upon the particular formulation of the composition and application. In the example, as reflected in Fig. 3, the polymer coating has partially broken down allowing resorption of the encapsulated calcium sulfate compound. Therein, the resorbing calcium sulfate compound produces deposits of calcium phosphate (CP) as in the first phase of resorption (see Fig. 2), and additional bone ingrowth will occur.
Fig. 4 shows the end result of the resorption of the implant composition. This occurs as early as six weeks or as late as twenty four weeks depending upon the particular formulation of the composition and application. By this time only residual amount of polymer material remains and full bone ingrowth has occurred. In addition, most calcium phosphate deposits have been removed by bone remodeling, only a small amount of calcium phosphate deposits within the original particles can still be visible in new bone growth. It is understood that bone remodeling is a natural process that normally occurs very slowly. Remodeling occurs as new bone is
constantly formed by osteoblasts and removed by osteoclasts. The balance of the two processes represents an equilibrium that determines how much bone is present at any given time. However, remodeling is rapid during healing, and virtually all of the immature bone that is formed during early healing is remodeled and replaced by more mature bone. The calcium phosphate deposits formed by the dissolving calcium sulfate are similar to bone mineral, and are also remodeled and replaced by more mature bone during this period of time.
The implant composition of the present invention can be used for the repair, augmentation, and other treatment of bone. The implant composition possesses significant advantages over existing calcium sulfate cements and pellets used clinically for bone repair and regeneration. More particularly, current calcium sulfate materials are resorbed by human bone within two to seven weeks, depending upon the calcium sulfate form and the particular surgical site, however, cannot be retained at the site for longer periods. As noted, such material is resorbed faster than it can be replaced by new bone thereby reducing its value to both patient and practitioner. The implant composition of the present invention can be designed to resorb in phases in accordance with the needs of a specific surgical application and environment of a recipient site, therein allowing substantial control of resorption rate. The resorption rate can be controlled of between eight and twenty four weeks, which substantially matches the rate of bone growth.
On the other hands, since methods involving separate use of calcium sulfate and polymeric components have long been established as safe and fully bioresorbable, clinical utilities and feasibility of the present invention are apparent. In particular, the implant composition of the present invention can be applied in dentistry for bone repairing and augmentation with or without a surgical implant.
Fig. 5 shows an example of using the implant composition of the present invention with a surgical implant. As shown, a surgical implant 10 is furnished at a surgical site 12 for the purpose of establishing bio-integration with surrounding bone tissue 14. An implant of the type of implant 10 includes buttress treads 16 (or other threading) and an integral collar 18 which comprises an upper part 20 and a lower part 22. Located above bone tissue 14 is a cortical bone layer 24, an optional bio-resorbable barrier layer 26 (described below) and a gum or soft tissue layer 28. The implant composition 30 of the present invention is filled in between bone tissue 14 and surgical implant 10 as an osseo-stimulative. It is to be understood that the implant composition can be applied to implant 10 before insertion into the osseotomy site or can be applied to the site 12, prior to insertion of the implant. Further, any of the surfaces of implant 10 inclusive of parts 20 and 22 of the collar 18 can be provided with cell growth stimulative microgeometry in accordance with our co-pending Application Serial No. 09/500,038. When a surgical
implant exhibits an entirely smooth external geometry, as is the case with an implant 50 in Fig. 6, an osseo-stimulative surface 52 (Fig. 7) made of the implant composition of the present invention is more suitable when physically adhered to the implant at a pre-operative site. It is, however, to be appreciated that a paste of the implant composition can be applied to an osseotomy site in combination with use of implant 50 and its osseo-stimulative surface 52.
The implant materials of the present invention can be sold as a kit. The kit can comprise dry powder of calcium sulfate compound, one or more types of polymer containing particles. The kit can further comprise a setting agent packed in a container. The kit can also include instructions on how to prepare the implant mixture, apply it in a recipient site and set it into the solid implant composition.
While there has been shown and described the preferred embodiment of the instant invention it is to be appreciated that the invention may be embodied otherwise than is herein specifically shown and described and that, within said embodiment, certain changes may be made in the form and arrangement of the parts without departing from the underlying ideas or principles of this invention as set forth herewith.
Claims (41)
1. An implant composition for stimulating bone growth, comprising:
(a) a calcium sulfate compound,
(b) polymer containing particles, and
(c) a setting agent for setting said calcium sulfate compound and said polymer containing particles into a heterogeneous solid composition, wherein upon setting, said calcium sulfate compound forms a matrix and said polymer containing particles are settled within said matrix.
2. The implant composition of Claim 1 , wherein a rate of resorption of said implant composition in a recipient site is in a range from about four weeks to about twenty eight weeks.
3. The implant composition of Claim 1, wherein said matrix and said polymer containing particles resorb at different rates in a recipient site, and resorption of said polymer containing particles being slower.
4. The implant composition of Claim 1, wherein said calcium sulfate compound is calcium sulfate hemihydrate.
5. The implant composition of Claim 1 , wherein said setting agent is selected from the group consisting of water, an alkaline metal salt solution, and a potassium salt solution.
6. The implant composition of Claim 1 , wherein said polymer containing particles comprises:
(a) a calcium sulfate compound, and
(b) at least one resorbable polymer.
7. The implant composition of Claim 6, wherein size of said polymer containing particles is more than 20 μm in diameter.
8. The implant composition of Claim 6, wherein said calcium sulfate compound in said polymer containing particles is selected from the group consisting of calcium sulfate dihydrate, calcium sulfate hemihydrate, and mixture thereof.
9. The implant composition of Claim 6, wherein said resorbable polymer is mixed with said calcium sulfate compound of said particles.
10. The implant composition of Claim 6, wherein said said calcium sulfate compound of said particles is coated with a resorbable polymer coating.
11. The implant composition of Claim 10, wherein thickness of said resorbable polymer coating is from about 2 μm to about 50 μm.
12. The implant composition of Claim 6, wherein said resorbable polymer is aliphatic polyesters of alpha-hydroxy acid derivatives.
13. The implant composition of Claim 12, wherein said resorbable polymer is selected from the group consisting of polyactides, polyglycolides, polydioxanone, and poly ε-caprolactone.
14. The implant composition of Claim 12, wherein said resorbable polymer is polyactides.
15. The implant composition of Claim 6, wherein said resorbable polymer is amino acid derived polymers selected from the group consisting of poly (DTE carbonates) and their derivatives.
16. The implant composition of Claim 6, wherein said resorbable polymer is selected from the group consisting of hydrophobic polymers, carnuba waxes and their derivatives, water soluble polymers, polyvinyl alcohols, and therapeutic polymers containing salicylates.
17. The method of Claim 6, wherein the amount of said resorbable polymer in said polymer containing particle is in a range from about 0.1% to about 50% (w/w).
18. A kit of implant materials for bone augmentation and bone defect reparation comprising:
(a) dry powder of a calcium sulfate compound, and
(b) polymer containing particles.
19. The kit of implant materials of Claim 18, wherein said calcium sulfate compound is calcium sulfate hemihydrate.
20. The kit of implant materials of Claim 18, wherein said polymer containing particles comprises:
(a) a calcium sulfate compound, and
(b) at least one resorbable polymer.
21. The kit of implant materials of Claim 20, wherein size of said polymer containing particles is more than 20 μm in diameter.
22. The kit of implant materials of Claim 20, wherein said calcium sulfate compound in said polymer containing particles is selected from the group consisting of calcium sulfate dihydrate, calcium sulfate hemihydrate, and mixture thereof.
23. The kit of implant materials of Claim 20, wherein said resorbable polymer is mixed with said calcium sulfate compound of said particles.
24. The kit of implant materials of Claim 20, wherein said calcium sulfate compound of said particles is coated with a resorbable polymer coating.
25. The kit of implant materials of Claim 24, wherein thickness of said resorbable polymer coating is from about 2 μm to about 50 μm.
26. The kit of implant materials of Claim 20, wherein said resorbable polymer is aliphatic polyesters of alpha-hydroxy acid derivatives.
27. The kit of implant materials of Claim 26, wherein said resorbable polymer is selected from the group consisting of polyactides, polyglycolides, polydioxanone, and poly ε-caprolactone.
28. The kit of implant materials of Claim 26, wherein said resorbable polymer is polyactides.
29. The kit of implant materials of Claim 20, wherein said resorbable polymer is ammo acid derived poiymers selected from the group consisting of poly (DTE carbonates) and their derivatives.
30. The kit of implant materials of Claim 20, wherein said resorbable polymer is selected from the group consisting of hydrophobic polymers, carnuba waxes and their derivatives, water soluble polymers, polyvinyl alcohols, and therapeutic polymers containing salicylates.
31. The kit of implant materials of Claim 20, wherein the amount of said resorbable polymer in said polymer containing particle is in a range from about 0.1% to about 30% (w/w).
32. The kit of implant materials of Claim 18, wherein said kit comprises two different types of polymer containing particles that resorb at different rates in a recipient site.
33. The kit of implant materials of Claim 18 further comprising a setting agent, packed in a container.
34. The kit of implant materials of Claim 33, wherein said setting agent is selected from the group consisting of water, an alkaline metal salt solution, and a potassium salt solution.
35. The kit of implant materials of Claim 18 further comprising instructions on how to use the kit.
36. A method for bone augmentation and bone defect reparation comprising the steps of:
(a) mixing a calcium sulfate compound and polymer containing particles with a setting agent into a mixture,
(b) applying said mixture, and
(c) setting said mixture into a heterogeneous solid composition, wherein upon setting, said calcium sulfate compound forms a matrix and said polymer containing particles settled within said matrix; wherein said heterogeneous solid composition resorbs at a controlled rate in a recipient site for stimulating bone growth.
37. The method of Claim 36, wherein applying said mixture is filling a recipient site with said mixture.
38. The method of Claim 36, wherein applying said mixture is coating said mixture on a surface of a surgical implant prior to introducing said surgical implant into said recipient site.
39. The method of Claim 36, wherein said setting agent controls a speed of setting said mixture into a heterogeneous solid composition.
40. The method of Claim 39, wherein said setting agent is selected from the group consisting of water, an alkaline metal salt solution, and a potassium salt solution.
41. The method of Claim 36, wherein said polymer containing particles are two different types of polymer containing particles that resorb at different rates in a recipient site.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006252084A AU2006252084B2 (en) | 2001-08-01 | 2006-12-18 | Time release calcium sulfate matrix for bone augmentation |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/918,445 US6770695B2 (en) | 2000-08-07 | 2001-08-01 | Time release calcium sulfate matrix for bone augmentation |
| US09/918,445 | 2001-08-01 | ||
| PCT/US2002/023981 WO2003011957A1 (en) | 2001-08-01 | 2002-07-26 | Time release calcium sulfate matrix for bone augmentation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006252084A Division AU2006252084B2 (en) | 2001-08-01 | 2006-12-18 | Time release calcium sulfate matrix for bone augmentation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2002330931C1 AU2002330931C1 (en) | 2003-02-17 |
| AU2002330931A1 true AU2002330931A1 (en) | 2003-05-29 |
| AU2002330931B2 AU2002330931B2 (en) | 2007-01-04 |
Family
ID=25440395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002330931A Ceased AU2002330931B2 (en) | 2001-08-01 | 2002-07-26 | Time release calcium sulfate matrix for bone augmentation |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6770695B2 (en) |
| EP (1) | EP1417256A4 (en) |
| JP (1) | JP4378501B2 (en) |
| KR (1) | KR100735191B1 (en) |
| CN (1) | CN100469825C (en) |
| AU (1) | AU2002330931B2 (en) |
| CA (1) | CA2454122A1 (en) |
| HK (1) | HK1068640A1 (en) |
| MX (1) | MXPA04000938A (en) |
| WO (1) | WO2003011957A1 (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7371408B1 (en) * | 1999-06-07 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US7488761B2 (en) * | 2000-08-07 | 2009-02-10 | Orthogen Llc | Polymer containing calcium sulfate particles for bone augmentation |
| US7575780B2 (en) * | 2000-08-07 | 2009-08-18 | Orthogen Llc | Method for manufacturing particles for use in forming a resorbable implant for stimulating bone growth |
| US7371409B2 (en) * | 2001-09-06 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| EP1344538A1 (en) * | 2002-03-14 | 2003-09-17 | Degradable Solutions AG | Porous biodegradable implant material and method for its fabrication |
| US20040127563A1 (en) * | 2002-03-22 | 2004-07-01 | Deslauriers Richard J. | Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
| EP1489998B1 (en) | 2002-03-29 | 2010-12-08 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US6652887B1 (en) | 2002-06-24 | 2003-11-25 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US7291179B2 (en) | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| EP1433489A1 (en) * | 2002-12-23 | 2004-06-30 | Degradable Solutions AG | Biodegradable porous bone implant with a barrier membrane sealed thereto |
| US7507257B2 (en) * | 2003-02-04 | 2009-03-24 | Wright Medical Technology, Inc. | Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects |
| US7572298B2 (en) * | 2003-03-28 | 2009-08-11 | Ethicon, Inc. | Implantable medical devices and methods for making same |
| US6893465B2 (en) * | 2003-03-31 | 2005-05-17 | Shi, Tain-Yew | Vividly simulated prosthetic intervertebral disc |
| WO2005039537A1 (en) | 2003-10-22 | 2005-05-06 | Lidds Ab | Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
| EP1789088A4 (en) | 2004-03-24 | 2009-12-30 | Doctor S Res Group Inc | Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods |
| US8163030B2 (en) * | 2004-05-06 | 2012-04-24 | Degradable Solutions Ag | Biocompatible bone implant compositions and methods for repairing a bone defect |
| US7250550B2 (en) * | 2004-10-22 | 2007-07-31 | Wright Medical Technology, Inc. | Synthetic bone substitute material |
| US8123787B2 (en) | 2004-10-28 | 2012-02-28 | Ogilvie James W | Method of treating scoliosis using a biological implant |
| US8641738B1 (en) | 2004-10-28 | 2014-02-04 | James W. Ogilvie | Method of treating scoliosis using a biological implant |
| CA2602419A1 (en) * | 2005-02-24 | 2006-08-31 | Roland Dricot | Bone implant |
| US7621963B2 (en) * | 2005-04-13 | 2009-11-24 | Ebi, Llc | Composite bone graft material |
| US8025903B2 (en) | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
| CA2619469C (en) * | 2005-09-09 | 2015-03-03 | Wright Medical Technology, Inc. | Composite bone graft cement comprising calcium sulfate dihydrate and brushite |
| US7833269B2 (en) * | 2006-01-25 | 2010-11-16 | Warsaw Orthopedic, Inc | Osteochondral implant procedure |
| EP1872807A1 (en) * | 2006-06-30 | 2008-01-02 | Scil Technology GmbH | Biomaterial containing degradation stabilized polymer |
| EP2234559A1 (en) * | 2008-01-09 | 2010-10-06 | Innovative Health Technologies, Llc | Implant pellets and methods for performing bone augmentation and preservation |
| JP2012500693A (en) * | 2008-08-27 | 2012-01-12 | ノレーカー | Bone substitute based on porous bioglass and calcium sulfate |
| IT1393814B1 (en) * | 2009-02-26 | 2012-05-11 | Univ Degli Studi Genova | COMPOSITE BIOMATERIAL AND PROCESS FOR ITS PREPARATION |
| US9180137B2 (en) | 2010-02-09 | 2015-11-10 | Bone Support Ab | Preparation of bone cement compositions |
| US8998925B2 (en) | 2011-06-20 | 2015-04-07 | Rdc Holdings, Llc | Fixation system for orthopedic devices |
| WO2012177759A1 (en) | 2011-06-20 | 2012-12-27 | Rdc Holdings, Llc | System and method for repairing joints |
| JP6318143B2 (en) * | 2012-04-11 | 2018-04-25 | インデュース バイオロジクス インコーポレイテッドＩｎｄｕｃｅ Ｂｉｏｌｏｇｉｃｓ Ｉｎｃ． | System and method for multiphasic release of growth factors |
| CA2901528C (en) | 2013-02-20 | 2022-07-26 | Bone Support Ab | Heat-treated, sintered and micronized hydroxyapatite powder for use in a hardenable bone substitute composition |
| TWI651103B (en) | 2013-12-13 | 2019-02-21 | 萊特醫技股份有限公司 | Multiphase bone graft replacement material |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5085861A (en) * | 1987-03-12 | 1992-02-04 | The Beth Israel Hospital Association | Bioerodable implant composition comprising crosslinked biodegradable polyesters |
| US5681873A (en) * | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
| AU3795395A (en) * | 1994-11-30 | 1996-06-06 | Ethicon Inc. | Hard tissue bone cements and substitutes |
| US6048521A (en) * | 1997-11-07 | 2000-04-11 | Rutgers, The State University | Copolymers of tyrosine-based polyarlates and poly(alkylene oxides) |
| WO2000007639A1 (en) * | 1998-08-07 | 2000-02-17 | Tissue Engineering, Inc. | Bone precursor compositions |
| US6224635B1 (en) * | 1998-11-06 | 2001-05-01 | Hospital For Joint Diseases | Implantation of surgical implants with calcium sulfate |
| US7371408B1 (en) * | 1999-06-07 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| WO2001032072A2 (en) * | 1999-11-01 | 2001-05-10 | Osteobiologics, Inc. | Biodegradable polymer/ceramic implant material with bimodal degradation profile |
| JP2003525696A (en) * | 2000-03-03 | 2003-09-02 | スミス アンド ネフュー インコーポレーテッド | Shaped particles and compositions for bone defects and methods of making the particles |
-
2001
- 2001-08-01 US US09/918,445 patent/US6770695B2/en not_active Expired - Fee Related
-
2002
- 2002-07-26 MX MXPA04000938A patent/MXPA04000938A/en not_active Application Discontinuation
- 2002-07-26 EP EP02768365A patent/EP1417256A4/en not_active Withdrawn
- 2002-07-26 AU AU2002330931A patent/AU2002330931B2/en not_active Ceased
- 2002-07-26 CA CA002454122A patent/CA2454122A1/en not_active Abandoned
- 2002-07-26 JP JP2003517141A patent/JP4378501B2/en not_active Expired - Lifetime
- 2002-07-26 WO PCT/US2002/023981 patent/WO2003011957A1/en active Application Filing
- 2002-07-26 CN CNB028170636A patent/CN100469825C/en not_active Expired - Fee Related
- 2002-07-26 KR KR1020047001268A patent/KR100735191B1/en not_active IP Right Cessation
-
2005
- 2005-02-04 HK HK05100948.8A patent/HK1068640A1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6770695B2 (en) | Time release calcium sulfate matrix for bone augmentation | |
| AU2002330931A1 (en) | Time release calcium sulfate matrix for bone augmentation | |
| US6582228B2 (en) | Surgical implant system, article and kit | |
| US4917702A (en) | Bone replacement material on the basis of carbonate and alkali containing calciumphosphate apatites | |
| Pietrzak et al. | Calcium sulfate bone void filler: a review and a look ahead | |
| US5296026A (en) | Phosphate glass cement | |
| US7575780B2 (en) | Method for manufacturing particles for use in forming a resorbable implant for stimulating bone growth | |
| US20090318982A1 (en) | Methods of injecting calcium based neutral and bioresorbable bone grafts | |
| JP2004528904A (en) | Calcium phosphate / sulfate based bone implant composition | |
| Murashima et al. | Calcium sulphate as a bone substitute for various osseous defects in conjunction with apicectomy. | |
| US7863352B2 (en) | Polymer containing calcium sulfate particles for bone augmentation | |
| Schepers et al. | Implant placement enhanced by bioactive glass particles of narrow size range. | |
| US20200061235A1 (en) | Macroporous Granules of Alkaline Earth Phosphates Using Cement Technology and Gas Evolving Porogen | |
| US20080233165A1 (en) | Time release calcium sulfate and growth factor matrix for bone augmentation | |
| AU2006252084B2 (en) | Time release calcium sulfate matrix for bone augmentation | |
| US20150050358A1 (en) | Implant support composition and methods of use | |
| EP3124057A1 (en) | Calcium phosphate-based biodegradable micro-screw and manufacturing method therefor | |
| WO2007046109A2 (en) | System and method for bone repair and/or bone augmentation | |
| WO2014133415A1 (en) | Method for producing a submerged dental implant from titanium or a titanium alloy and dental implant made from titanium or a titanium alloy | |
| KIMURA et al. | A Study of the Apatite-Collagen Composites Part I: Disintegration Properties and Biological Responses | |
| Aldelaimi et al. | The Use of Resorbable Tricalcium Phosphate Material (β TCP) in Treatment of Surgical Bony Defects after Minor Surgical Procedures | |
| 木村博 et al. | A Study of the Apatite-Collagen Composites | |
| Hampshire | Bioglasses Bioglasses and Bioglass-ceramics | |
| RICCI et al. | New York University College of Dentistry, USA and S MAMIDWAR and H ALEXANDER, Orthogen Corporation, USA |